MedTrace Logo

Stanford Letter or Traditional Advance Directive in Advance Care Planning in Patients Undergoing Bone Marrow Transplant

NCT03028961 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2022-06-14

No results posted yet for this study

Summary

The purpose of the proposed research study is to evaluate whether bone marrow transplant patients prefer the Stanford letter advance care planning tool to the standard Advance directive.

Completion of advance care planning prior to BMT is very important, but not often done. The investigators believe that the Stanford Letter will be preferred by patients and will allow them to feel more comfortable and share more of their wishes with family members and the medical team.

Conditions

  • Advance Directives
  • Bone Marrow Transplant

Interventions

OTHER

Stanford Letter

Receive and complete the Stanford Letter

OTHER

Interview

Undergo semi-structured, research staff-led interview

OTHER

Questionnaire Administration

Ancillary studies

OTHER

CA Advance Health Care Directive Form

Receive and complete the CA Advance Health Care Directive Form

Sponsors & Collaborators

Principal Investigators

  • Lori Muffly, MD · Stanford Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-03
Primary Completion
2018-09-14
Completion
2021-07-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03028961 on ClinicalTrials.gov